Cite
APA Citation
McGarvey, L., Niewoehner, D., Magder, S., Sachs, P., Tetzlaff, K., Hamilton, A., Korducki, L., Bothner, U., Vogelmeier, C., Koch, A., & Ferguson, G. T. (n.d.). one-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2–4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis. COPD, 12, 484–493. http://access.bl.uk/ark:/81055/vdc_100089568653.0x000008